Company: XAIR
Filing Date: 2025-02-14
Form Type: 424B5
Source: 0001493152-25-006903
Chunk: 16

Company: Beyond Air, Inc.
Filing Date: 2025-02-14
Form: 424B5
Chunk 16
---
 assumes for illustrative purposes that an aggregate of 26,736,534 shares of our common stock are sold during the term of the sales agreement with the agent at a price of $0.37 per share, the last reported sale price of our common stock on the Nasdaq Capital Market on February 13, 2025 for aggregate gross proceeds of $9,892,518. The shares sold in this offering, if any, will be sold from time to time at various prices. An increase of $0.10 per share in the price at which the shares are sold from the assumed offering price of $0.37 per share, assuming all of our common stock in the aggregate amount of $9,892,518 during the term of the sales agreement with the agent is sold at that price, would increase our adjusted net tangible book value per share after the offering to $0.26 per share and would increase the dilution in net tangible book value per share to new investors in this offering to $0.21 per share, after deducting commissions and estimated offering expenses payable by us. A decrease of $0.10 per share in the price at which the shares are sold from the assumed offering price of $0.37 per share, assuming all of our common stock in the aggregate amount of $9,892,518 is sold at that price, would decrease our adjusted net tangible book value per share after the offering to $0.22 per share and would decrease the dilution in net tangible book value per share to new investors in this offering to $0.05 per share, after deducting commissions and estimated offering expenses payable by us. This information is supplied for illustrative purposes only.

We may choose to raise additional capital due to market conditions or strategic considerations even if we believe we have sufficient funds for our current or future operating plans. To the extent that additional capital is raised through the sale of equity or convertible debt securities, the issuance of these securities may result in further dilution to our shareholders. To the extent that outstanding options or warrants outstanding as of December 31, 2024 have been or may be exercised or other shares issued, investors purchasing our common stock in this offering may experience further dilution.

| S-10 |

<div align='center'>PLAN OF DISTRIBUTION</div>

We have entered into a sales agreement with BTIG, LLC, under which we may issue and sell from time to time up to $35,000,000 of our common stock through BTIG, LLC as our sales